*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Food/NNP ]
and/CC 
[ Drug/NNP Administration/NNP investigators/NNS ]
have/VBP reported/VBN that/IN 
[ employees/NNS ]
at/IN 
[ Eli/NNP Lilly/NNP ]
&/CC 
[ Co./NNP 's/POS Indianapolis/NNP plant/NN ]
submitted/VBD 
[ false/JJ ]
or/CC 
[ incomplete/JJ data/NNS ]
to/TO 
[ the/DT FDA/NNP ]
on/IN 
[ some/DT ]
of/IN 
[ the/DT drugs/NNS ]

[ it/PRP ]
made/VBD ./. 

======================================

In/IN 
[ two/CD instances/NNS ]
,/, 
[ investigators/NNS ]
wrote/VBD ,/, 
[ the/DT plant/NN ]
failed/VBD to/TO report/VB to/TO 
[ the/DT FDA/NNP ]
that/IN 
[ drugs/NNS ]
failed/VBD 
[ tests/NNS ]
for/IN 
[ stability/NN ]
./. 

[ Such/JJ tests/NNS ]
indicate/VBP 
[ a/DT drug/NN 's/POS ability/NN ]
to/TO work/VB as/IN promised/VBN after/IN 
[ a/DT certain/JJ amount/NN ]
of/IN 
[ time/NN ]
./. 

======================================

[ Congressional/JJ investigators/NNS ]
said/VBD 
[ they/PRP ]
plan/VBP to/TO examine/VB 
[ those/DT ]
and/CC 
[ other/JJ incidents/NNS ]
cited/VBN by/IN 
[ FDA/NNP investigators/NNS ]
./. 

``/`` 
[ It/PRP ]
's/VBZ fair/JJ to/TO say/VB 
[ the/DT committee/NN ]
is/VBZ looking/VBG at/IN 
[ that/DT ]
,/, ''/'' said/VBD 
[ a/DT staff/NN member/NN ]
of/IN 
[ the/DT investigations/NNS subcommittee/NN ]
of/IN 
[ the/DT House/NNP Energy/NNP ]
and/CC 
[ Commerce/NNP Committee/NNP ]
./. 

``/`` 
[ That/DT ]
goes/VBZ to/TO 
[ the/DT question/NN ]
of/IN 
[ obfuscation/NN ]
./. 

''/'' 
======================================

[ A/DT Lilly/NNP spokesman/NN ]
said/VBD 
[ the/DT incidents/NNS ]
were/VBD ``/`` 
[ technical/JJ aberrations/NNS ]
''/'' and/CC that/IN 
[ the/DT company/NN ]
is/VBZ addressing/VBG 
[ them/PRP ]
in/IN 
[ its/PRP$ plan/NN ]
to/TO fix/VB 
[ the/DT problems/NNS ]
at/IN 
[ the/DT plant/NN ]
./. 

[ Lilly/NNP ]
has/VBZ said/VBD 
[ it/PRP ]
's/VBZ reviewing/VBG 
[ its/PRP$ manufacturing/NN operations/NNS ]
and/CC 
[ its/PRP$ goal/NN ]
is/VBZ to/TO ``/`` address/VB 
[ all/DT ]
of/IN 
[ the/DT issues/NNS ]
raised/VBN by/IN 
[ the/DT FDA/NNP ]
./. 

''/'' 
[ Last/JJ week/NN ]
,/, 
[ it/PRP ]
halted/VBD 
[ the/DT distribution/NN ]
of/IN 
[ all/DT drugs/NNS ]
made/VBN at/IN 
[ the/DT Indianapolis/NNP plant/NN ]
and/CC recalled/VBD 
[ 10/CD drugs/NNS ]
./. 

======================================

In/IN 
[ a/DT related/VBN development/NN ]
,/, 
[ subcommittee/NN Chairman/NNP John/NNP D./NNP Dingell/NNP late/JJ yesterday/NN ]
asked/VBD 
[ Lilly/NNP ]
for/IN 
[ copies/NNS ]
of/IN 
[ company/NN documents/NNS ]
and/CC 
[ records/NNS ]
of/IN 
[ inspections/NNS ]
of/IN 
[ its/PRP$ facilities/NNS ]
from/IN 
[ 1985/CD ]
to/TO 
[ the/DT present/NN ]
,/, including/VBG 
[ a/DT list/NN ]
of/IN 
[ management/NN ]
at/IN 
[ the/DT Indianapolis/NNP plant/NN ]
./. 

In/IN 
[ a/DT letter/NN ]
to/TO 
[ Lilly/NNP Chairman/NNP Richard/NNP D./NNP Wood/NNP ]
,/, 
[ Mr./NNP Dingell/NNP ]
said/VBD 
[ the/DT FDA/NNP report/NN ]
``/`` confirmed/VBN that/IN 
[ callous/JJ ]
and/CC 
[ cavalier/JJ business/NN practices/NNS ]
were/VBD 
[ commonplace/JJ ]
''/'' in/IN 
[ the/DT plant/NN ]
./. 

======================================

[ A/DT Lilly/NNP spokesman/NN ]
said/VBD 
[ he/PRP ]
could/MD n't/RB comment/VB because/IN 
[ the/DT company/NN ]
had/VBD not/RB yet/RB seen/VBN 
[ the/DT letter/NN ]
./. 

======================================

[ Last/JJ week/NN ]
,/, 
[ Mr./NNP Dingell/NNP ]
asked/VBD 
[ the/DT FDA/NNP ]
for/IN 
[ inspection/NN records/NNS ]
of/IN more/RBR than/IN 
[ 50/CD Lilly/NNP ]
manufacturing/NN 
[ plants/NNS ]
./. 

[ That/DT request/NN ]
came/VBD in/IN 
[ the/DT wake/NN ]
of/IN 
[ the/DT investigators/NNS '/POS findings/NNS ]
of/IN 
[ widespread/JJ problems/NNS ]
at/IN 
[ the/DT Indianapolis/NNP plant/NN ]
,/, 
[ which/WDT ]
makes/VBZ 
[ drug/NN tablets/NNS ]
and/CC 
[ capsules/NNS ]
./. 

[ The/DT examination/NN ]
of/IN 
[ Lilly/NNP ]
,/, 
[ one/CD ]
of/IN 
[ the/DT biggest/JJS makers/NNS ]
of/IN 
[ brand-name/JJ drugs/NNS ]
,/, marked/VBD 
[ a/DT broadening/NN ]
of/IN 
[ the/DT subcommittee/NN 's/POS investigation/NN ]
./. 

[ It/PRP ]
had/VBD been/VBN investigating/VBG 
[ alleged/JJ wrongdoing/NN ]
by/IN 
[ makers/NNS ]
of/IN 
[ generic/JJ drugs/NNS ]
./. 

======================================

Although/IN 
[ an/DT FDA/NNP spokesman/NN ]
said/VBD 
[ the/DT investigation/NN ]
found/VBD ``/`` 
[ a/DT number/NN ]
of/IN 
[ objectionable/JJ practices/NNS ]
,/, ''/'' 
[ he/PRP ]
said/VBD 
[ they/PRP ]
are/VBP different/JJ from/IN 
[ those/DT ]
found/VBN in/IN 
[ the/DT investigation/NN ]
of/IN 
[ generic/JJ drug/NN makers/NNS ]
./. 

For/IN 
[ example/NN ]
,/, 
[ FDA/NNP officials/NNS ]
said/VBD 
[ they/PRP ]
have/VBP 
[ no/DT evidence/NN ]
of/IN 
[ fraud/NN ]
at/IN Lilly/NNP ./. 

======================================

In/IN 
[ the/DT stability/NN tests/NNS ]
,/, 
[ investigators/NNS ]
said/VBD that/IN 
[ four/CD lots/NNS ]
of/IN 
[ the/DT antibiotic/NN Ilotycin/NNP ]
showed/VBD 
[ failures/NNS ]
for/IN 
[ moisture/NN ]
,/, but/CC 
[ that/DT ]
reports/VBZ to/TO 
[ the/DT FDA/NNP ]
did/VBD n't/RB mention/VB 
[ that/DT ]
./. 

[ They/PRP ]
also/RB found/VBD that/IN 
[ a/DT 1985/CD ]
Lilly/NNP 
[ report/NN ]
to/TO 
[ the/DT FDA/NNP ]
extended/VBD 
[ the/DT expiration/NN date/NN ]
for/IN 
[ the/DT drug/NN ]
to/TO 
[ four/CD years/NNS ]
from/IN 
[ two/CD ]
even/RB though/IN 
[ stability/NN ]
for/IN 
[ the/DT marketed/VBN lots/NNS ]
had/VBD 
[ those/DT failures/NNS ]
./. 

======================================

[ Moisture/NN ]
is/VBZ 
[ one/CD ]
of/IN 
[ a/DT number/NN ]
of/IN 
[ tests/NNS ]
to/TO check/VB 
[ stability/NN ]
./. 

[ Too/RB much/JJ moisture/NN ]
,/, for/IN 
[ example/NN ]
,/, can/MD make/VB 
[ a/DT drug/NN ]
degrade/VB more/RBR quickly/RB and/CC thus/RB hurt/VB 
[ its/PRP$ effectiveness/NN ]
./. 

[ A/DT Lilly/NNP spokesman/NN ]
said/VBD 
[ Ilotycin/NNP was/VBD n't/RB ]
recalled/VBN and/CC that/IN 
[ the/DT company/NN ]
considers/VBZ 
[ the/DT drug/NN safe/NN ]
./. 

======================================

In/IN 
[ a/DT separate/JJ incident/NN ]
,/, 
[ the/DT investigators/NNS ]
said/VBD 
[ Lilly/NNP ]
signed/VBD off/RP on/IN 
[ a/DT validation/NN ]
for/IN 
[ Darvon/NNP compound/NN two/CD years/NNS ]
late/RB and/CC 
[ four/CD days/NNS ]
after/IN 
[ the/DT FDA/NNP ]
started/VBD 
[ its/PRP$ investigation/NN ]
in/IN 
[ April/NNP ]
./. 

[ They/PRP ]
said/VBD 
[ the/DT sign-off/NN ]
was/VBD contrary/JJ to/TO 
[ Lilly/NNP 's/POS standard/JJ operating/NN procedures/NNS ]
and/CC was/VBD done/VBN even/RB though/IN 
[ the/DT product/NN ]
had/VBD long/RB since/IN been/VBN recalled/VBN ./. 

======================================

[ Darvon/NNP compound/NN ]
is/VBZ made/VBN up/IN of/IN 
[ the/DT painkiller/NN Darvon/NNP ]
plus/IN 
[ aspirin/NN ]
and/CC 
[ caffeine/NN ]
./. 

======================================

Lilly/RB has/VBZ said/VBD 
[ the/DT report/NN ]
does/VBZ n't/RB call/VB into/IN 
[ question/NN ]

[ the/DT safety/NN ]
or/CC 
[ effectiveness/NN ]
of/IN 
[ any/DT ]
of/IN 
[ its/PRP$ products/NNS ]
./. 

======================================

``/`` 
[ They/PRP ]
may/MD be/VB right/JJ ,/, ''/'' said/VBD 
[ Sidney/NNP Wolfe/NNP ]
,/, 
[ who/WP ]
,/, as/IN 
[ director/NN ]
of/IN 
[ the/DT Public/NNP Citizen/NNP Health/NNP Research/NNP Group/NNP ]
,/, has/VBZ been/VBN 
[ a/DT vocal/NN critic/NN ]
of/IN 
[ drug/NN companies/NNS ]
./. 

``/`` But/CC if/IN 
[ the/DT company/NN ]
continued/VBD 
[ such/JJ widespread/JJ violations/NNS ]
of/IN 
[ the/DT way/NN drugs/NNS ]
should/MD be/VB manufactured.../: sooner/RB or/CC later/RB 
[ they/PRP ]
might/MD cause/VB 
[ a/DT lot/NN ]
of/IN 
[ injuries/NNS ]
./. 

''/'' 
======================================

[ The/DT investigators/NNS ]
also/RB reported/VBD 
[ two/CD instances/NNS ]
when/WRB 
[ employees/NNS ]
apparently/RB signed/VBD 
[ records/NNS ]
without/IN seeing/VBG 
[ the/DT processing/VBG steps/NNS they/PRP ]
were/VBD verifying/VBG ./. 

======================================

[ One/CD instance/NN ]
involved/VBD weighing/VBG 
[ a/DT batch/NN ]
of/IN 
[ Darvocet-N/NNP 50/CD ]
,/, 
[ another/DT painkiller/NN ]
./. 

[ Accurate/JJ weights/NNS ]
are/VBP such/JJ 
[ a/DT vital/JJ part/NN ]
of/IN 
[ the/DT drug-making/JJ process/NN ]
that/IN 
[ a/DT second/JJ person/NN ]
is/VBZ required/VBN to/TO verify/VB 
[ the/DT weights/NNS ]
./. 

======================================

But/CC 
[ the/DT investigators/NNS ]
said/VBD 
[ they/PRP ]
talked/VBD with/IN 
[ a/DT supervisor/NN ]
after/IN finding/VBG that/IN 
[ verification/NN steps/NNS ]
were/VBD n't/RB recorded/VBN for/IN 
[ certain/JJ lots/NNS ]
of/IN 
[ the/DT painkiller/NN ]
./. 

======================================

``/`` 
[ A/DT few/JJ minutes/NNS ]
later/RB ,/, ''/'' 
[ the/DT report/NN ]
states/VBZ ,/, ``/`` 
[ the/DT supervisor/NN ]
was/VBD seen/VBN entering/VBG 
[ the/DT tablet/NN manufacturing/VBG room/NN ]
where/WRB 
 
{/( 
[ another/DT lot/NN ]
 }/) was/VBD being/VBG processed/VBN ,/, and/CC initialed/VBD 
[ the/DT batch/NN record/NN ]
without/IN actually/RB verifying/VBG 
[ the/DT weights/NNS ]
./. 

''/'' 
======================================

Although/IN 
[ Lilly/NNP ]
would/MD n't/RB comment/VB about/IN 
[ individual/JJ incidents/NNS ]
in/IN 
[ the/DT report/NN ]
,/, 
[ its/PRP$ response/NN ]
to/TO 
[ the/DT FDA/NNP 's/POS inspection/NN ]
says/VBZ 
[ its/PRP$ training/NN program/NN ]
will/MD ``/`` reinforce/VB ''/'' 
[ its/PRP$ policy/NN ]

[ that/WDT ]
employees/NNS ``/`` 
[ initial/VB ]
only/RB 
[ those/DT steps/NNS ]
or/CC 
[ actions/NNS ]
that/IN 
[ they/PRP ]
perform/VBP ,/, verify/VBP or/CC observe/VBP ./. 

''/'' 
======================================

[ The/DT three/CD FDA/NNP investigators/NNS ]
spent/VBD 
[ four/CD months/NNS ]
examining/VBG 
[ the/DT manufacturing/NN ]
and/CC 
[ control/NN systems/NNS ]
of/IN 
[ the/DT plant/NN ]
./. 

[ The/DT 90-page/JJ report/NN ]
,/, 
[ which/WDT ]
is/VBZ unusually/RB long/JJ for/IN 
[ such/JJ investigations/NNS ]
,/, 
[ details/VBZ problems/NNS ]

[ the/DT investigators/NNS ]
said/VBD 
[ they/PRP ]
found/VBD ``/`` in/IN nearly/RB 
[ every/DT area/NN ]
inspected/VBD ./. 
